nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—ABCB1—Naltrexone—alcohol dependence	0.176	0.296	CbGbCtD
Pomalidomide—CYP1A2—Citalopram—alcohol dependence	0.134	0.225	CbGbCtD
Pomalidomide—ABCB1—Citalopram—alcohol dependence	0.117	0.196	CbGbCtD
Pomalidomide—CYP3A4—Disulfiram—alcohol dependence	0.0982	0.165	CbGbCtD
Pomalidomide—CYP3A4—Citalopram—alcohol dependence	0.07	0.118	CbGbCtD
Pomalidomide—TNF—blood—alcohol dependence	0.00551	0.0858	CbGeAlD
Pomalidomide—Neuropathy—Disulfiram—alcohol dependence	0.00534	0.0217	CcSEcCtD
Pomalidomide—Night sweats—Naltrexone—alcohol dependence	0.00491	0.0199	CcSEcCtD
Pomalidomide—ABCB1—Abacavir transport and metabolism—ADH1A—alcohol dependence	0.00464	0.051	CbGpPWpGaD
Pomalidomide—Platelet count decreased—Naltrexone—alcohol dependence	0.00445	0.0181	CcSEcCtD
Pomalidomide—Deep vein thrombosis—Naltrexone—alcohol dependence	0.00435	0.0177	CcSEcCtD
Pomalidomide—Musculoskeletal chest pain—Citalopram—alcohol dependence	0.00433	0.0176	CcSEcCtD
Pomalidomide—CRBN—forebrain—alcohol dependence	0.00394	0.0613	CbGeAlD
Pomalidomide—Thalidomide—CYP2E1—alcohol dependence	0.00372	1	CrCbGaD
Pomalidomide—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.0037	0.0407	CbGpPWpGaD
Pomalidomide—CRBN—adrenal cortex—alcohol dependence	0.00365	0.0568	CbGeAlD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.0035	0.0385	CbGpPWpGaD
Pomalidomide—Lymphopenia—Citalopram—alcohol dependence	0.00328	0.0133	CcSEcCtD
Pomalidomide—CRBN—pancreas—alcohol dependence	0.00324	0.0504	CbGeAlD
Pomalidomide—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00312	0.0127	CcSEcCtD
Pomalidomide—Night sweats—Citalopram—alcohol dependence	0.00311	0.0126	CcSEcCtD
Pomalidomide—Hyperbilirubinaemia—Acamprosate—alcohol dependence	0.00308	0.0125	CcSEcCtD
Pomalidomide—CYP1A2—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00307	0.0337	CbGpPWpGaD
Pomalidomide—CRBN—gonad—alcohol dependence	0.00302	0.047	CbGeAlD
Pomalidomide—TNF—Allograft Rejection—PECR—alcohol dependence	0.003	0.033	CbGpPWpGaD
Pomalidomide—Platelet count decreased—Citalopram—alcohol dependence	0.00282	0.0115	CcSEcCtD
Pomalidomide—Pulmonary embolism—Acamprosate—alcohol dependence	0.0028	0.0114	CcSEcCtD
Pomalidomide—CRBN—digestive system—alcohol dependence	0.00277	0.043	CbGeAlD
Pomalidomide—Pelvic pain—Citalopram—alcohol dependence	0.00276	0.0112	CcSEcCtD
Pomalidomide—Deep vein thrombosis—Citalopram—alcohol dependence	0.00276	0.0112	CcSEcCtD
Pomalidomide—Respiratory tract infection—Citalopram—alcohol dependence	0.00267	0.0108	CcSEcCtD
Pomalidomide—Pulmonary embolism—Naltrexone—alcohol dependence	0.00265	0.0108	CcSEcCtD
Pomalidomide—CRBN—blood—alcohol dependence	0.00264	0.041	CbGeAlD
Pomalidomide—Embolism—Citalopram—alcohol dependence	0.00261	0.0106	CcSEcCtD
Pomalidomide—CRBN—midbrain—alcohol dependence	0.0026	0.0405	CbGeAlD
Pomalidomide—CYP1A2—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00254	0.028	CbGpPWpGaD
Pomalidomide—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00237	0.026	CbGpPWpGaD
Pomalidomide—CRBN—endocrine gland—alcohol dependence	0.00229	0.0356	CbGeAlD
Pomalidomide—PTGS2—Eicosanoid Synthesis—GGT2—alcohol dependence	0.00225	0.0248	CbGpPWpGaD
Pomalidomide—CRBN—testis—alcohol dependence	0.00218	0.0339	CbGeAlD
Pomalidomide—CYP1A2—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00216	0.0238	CbGpPWpGaD
Pomalidomide—CRBN—nervous system—alcohol dependence	0.00214	0.0333	CbGeAlD
Pomalidomide—Cardiac failure congestive—Naltrexone—alcohol dependence	0.00212	0.00861	CcSEcCtD
Pomalidomide—CRBN—liver—alcohol dependence	0.00206	0.0321	CbGeAlD
Pomalidomide—CRBN—central nervous system—alcohol dependence	0.00206	0.032	CbGeAlD
Pomalidomide—Hyponatraemia—Acamprosate—alcohol dependence	0.00204	0.00829	CcSEcCtD
Pomalidomide—Atrial fibrillation—Naltrexone—alcohol dependence	0.00203	0.00824	CcSEcCtD
Pomalidomide—CRBN—cerebellum—alcohol dependence	0.00201	0.0313	CbGeAlD
Pomalidomide—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00196	0.0216	CbGpPWpGaD
Pomalidomide—Pain in extremity—Naltrexone—alcohol dependence	0.00192	0.00781	CcSEcCtD
Pomalidomide—Blood creatinine increased—Acamprosate—alcohol dependence	0.0019	0.00774	CcSEcCtD
Pomalidomide—Dry skin—Acamprosate—alcohol dependence	0.00186	0.00757	CcSEcCtD
Pomalidomide—Hyperbilirubinaemia—Citalopram—alcohol dependence	0.00185	0.0075	CcSEcCtD
Pomalidomide—CYP1A2—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00184	0.0202	CbGpPWpGaD
Pomalidomide—Breast disorder—Acamprosate—alcohol dependence	0.00184	0.00746	CcSEcCtD
Pomalidomide—Hypocalcaemia—Citalopram—alcohol dependence	0.00183	0.00745	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00179	0.00728	CcSEcCtD
Pomalidomide—Dehydration—Naltrexone—alcohol dependence	0.00179	0.00726	CcSEcCtD
Pomalidomide—Bone pain—Citalopram—alcohol dependence	0.00175	0.00712	CcSEcCtD
Pomalidomide—Fatigue—Disulfiram—alcohol dependence	0.00175	0.0071	CcSEcCtD
Pomalidomide—Pain—Disulfiram—alcohol dependence	0.00173	0.00704	CcSEcCtD
Pomalidomide—Nasopharyngitis—Naltrexone—alcohol dependence	0.00172	0.00699	CcSEcCtD
Pomalidomide—Musculoskeletal pain—Citalopram—alcohol dependence	0.0017	0.0069	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.0017	0.00689	CcSEcCtD
Pomalidomide—Bronchitis—Acamprosate—alcohol dependence	0.00169	0.00686	CcSEcCtD
Pomalidomide—Pulmonary embolism—Citalopram—alcohol dependence	0.00168	0.00682	CcSEcCtD
Pomalidomide—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00167	0.0183	CbGpPWpGaD
Pomalidomide—CRBN—brain—alcohol dependence	0.00164	0.0254	CbGeAlD
Pomalidomide—TNF—Monoamine Transport—SLC6A4—alcohol dependence	0.00163	0.0179	CbGpPWpGaD
Pomalidomide—Depressed level of consciousness—Citalopram—alcohol dependence	0.00162	0.00658	CcSEcCtD
Pomalidomide—CYP1A2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00162	0.0178	CbGpPWpGaD
Pomalidomide—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00161	0.0177	CbGpPWpGaD
Pomalidomide—Weight increased—Acamprosate—alcohol dependence	0.0016	0.00649	CcSEcCtD
Pomalidomide—Bronchitis—Naltrexone—alcohol dependence	0.0016	0.00649	CcSEcCtD
Pomalidomide—Weight decreased—Acamprosate—alcohol dependence	0.00159	0.00646	CcSEcCtD
Pomalidomide—Hyperglycaemia—Acamprosate—alcohol dependence	0.00158	0.00644	CcSEcCtD
Pomalidomide—Neuropathy—Citalopram—alcohol dependence	0.00158	0.0064	CcSEcCtD
Pomalidomide—Pneumonia—Acamprosate—alcohol dependence	0.00158	0.0064	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00154	0.00628	CcSEcCtD
Pomalidomide—CYP1A2—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00154	0.0169	CbGpPWpGaD
Pomalidomide—Urinary tract infection—Acamprosate—alcohol dependence	0.00152	0.00618	CcSEcCtD
Pomalidomide—Weight increased—Naltrexone—alcohol dependence	0.00151	0.00614	CcSEcCtD
Pomalidomide—Weight decreased—Naltrexone—alcohol dependence	0.0015	0.00611	CcSEcCtD
Pomalidomide—Pneumonia—Naltrexone—alcohol dependence	0.00149	0.00606	CcSEcCtD
Pomalidomide—Infestation—Naltrexone—alcohol dependence	0.00148	0.00602	CcSEcCtD
Pomalidomide—Infestation NOS—Naltrexone—alcohol dependence	0.00148	0.00602	CcSEcCtD
Pomalidomide—Epistaxis—Acamprosate—alcohol dependence	0.00148	0.006	CcSEcCtD
Pomalidomide—Sepsis—Citalopram—alcohol dependence	0.00146	0.00592	CcSEcCtD
Pomalidomide—Asthenia—Disulfiram—alcohol dependence	0.00145	0.00591	CcSEcCtD
Pomalidomide—TNF—Monoamine Transport—SLC6A3—alcohol dependence	0.00145	0.016	CbGpPWpGaD
Pomalidomide—Urinary tract infection—Naltrexone—alcohol dependence	0.00144	0.00585	CcSEcCtD
Pomalidomide—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00142	0.0156	CbGpPWpGaD
Pomalidomide—Hepatobiliary disease—Naltrexone—alcohol dependence	0.0014	0.00569	CcSEcCtD
Pomalidomide—Epistaxis—Naltrexone—alcohol dependence	0.0014	0.00568	CcSEcCtD
Pomalidomide—Oedema peripheral—Acamprosate—alcohol dependence	0.00138	0.00563	CcSEcCtD
Pomalidomide—Dizziness—Disulfiram—alcohol dependence	0.00134	0.00545	CcSEcCtD
Pomalidomide—ABCB1—Allograft Rejection—PECR—alcohol dependence	0.00131	0.0145	CbGpPWpGaD
Pomalidomide—Connective tissue disorder—Naltrexone—alcohol dependence	0.00131	0.00531	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00129	0.0142	CbGpPWpGaD
Pomalidomide—Atrial fibrillation—Citalopram—alcohol dependence	0.00129	0.00522	CcSEcCtD
Pomalidomide—Rash—Disulfiram—alcohol dependence	0.00128	0.00519	CcSEcCtD
Pomalidomide—Headache—Disulfiram—alcohol dependence	0.00127	0.00516	CcSEcCtD
Pomalidomide—Chills—Acamprosate—alcohol dependence	0.00126	0.00513	CcSEcCtD
Pomalidomide—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00125	0.0137	CbGpPWpGaD
Pomalidomide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00124	0.0137	CbGpPWpGaD
Pomalidomide—Cardiac disorder—Naltrexone—alcohol dependence	0.00123	0.00502	CcSEcCtD
Pomalidomide—Mental disorder—Acamprosate—alcohol dependence	0.00123	0.005	CcSEcCtD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00123	0.0135	CbGpPWpGaD
Pomalidomide—Malnutrition—Acamprosate—alcohol dependence	0.00122	0.00497	CcSEcCtD
Pomalidomide—Hyponatraemia—Citalopram—alcohol dependence	0.00122	0.00497	CcSEcCtD
Pomalidomide—Pain in extremity—Citalopram—alcohol dependence	0.00122	0.00495	CcSEcCtD
Pomalidomide—Angiopathy—Naltrexone—alcohol dependence	0.00121	0.0049	CcSEcCtD
Pomalidomide—Mediastinal disorder—Naltrexone—alcohol dependence	0.0012	0.00487	CcSEcCtD
Pomalidomide—Chills—Naltrexone—alcohol dependence	0.00119	0.00485	CcSEcCtD
Pomalidomide—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00119	0.013	CbGpPWpGaD
Pomalidomide—Back pain—Acamprosate—alcohol dependence	0.00118	0.00481	CcSEcCtD
Pomalidomide—Muscle spasms—Acamprosate—alcohol dependence	0.00118	0.00478	CcSEcCtD
Pomalidomide—Mental disorder—Naltrexone—alcohol dependence	0.00117	0.00473	CcSEcCtD
Pomalidomide—Urinary retention—Citalopram—alcohol dependence	0.00116	0.00471	CcSEcCtD
Pomalidomide—Malnutrition—Naltrexone—alcohol dependence	0.00116	0.0047	CcSEcCtD
Pomalidomide—Tremor—Acamprosate—alcohol dependence	0.00115	0.00466	CcSEcCtD
Pomalidomide—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00114	0.0125	CbGpPWpGaD
Pomalidomide—Dehydration—Citalopram—alcohol dependence	0.00113	0.0046	CcSEcCtD
Pomalidomide—Anaemia—Acamprosate—alcohol dependence	0.00113	0.0046	CcSEcCtD
Pomalidomide—Back pain—Naltrexone—alcohol dependence	0.00112	0.00455	CcSEcCtD
Pomalidomide—Dry skin—Citalopram—alcohol dependence	0.00112	0.00454	CcSEcCtD
Pomalidomide—Muscle spasms—Naltrexone—alcohol dependence	0.00111	0.00452	CcSEcCtD
Pomalidomide—Hypokalaemia—Citalopram—alcohol dependence	0.00111	0.0045	CcSEcCtD
Pomalidomide—Breast disorder—Citalopram—alcohol dependence	0.0011	0.00447	CcSEcCtD
Pomalidomide—Vertigo—Acamprosate—alcohol dependence	0.0011	0.00447	CcSEcCtD
Pomalidomide—Leukopenia—Acamprosate—alcohol dependence	0.0011	0.00445	CcSEcCtD
Pomalidomide—Nasopharyngitis—Citalopram—alcohol dependence	0.00109	0.00443	CcSEcCtD
Pomalidomide—Tremor—Naltrexone—alcohol dependence	0.00108	0.00441	CcSEcCtD
Pomalidomide—Muscular weakness—Citalopram—alcohol dependence	0.00107	0.00437	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00107	0.00437	CcSEcCtD
Pomalidomide—PTGS2—forebrain—alcohol dependence	0.00107	0.0167	CbGeAlD
Pomalidomide—Cough—Acamprosate—alcohol dependence	0.00107	0.00434	CcSEcCtD
Pomalidomide—PTGS2—Eicosanoid Synthesis—GGT1—alcohol dependence	0.00106	0.0117	CbGpPWpGaD
Pomalidomide—Arthralgia—Acamprosate—alcohol dependence	0.00104	0.00423	CcSEcCtD
Pomalidomide—Anxiety—Acamprosate—alcohol dependence	0.00104	0.00422	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00103	0.0042	CcSEcCtD
Pomalidomide—Bronchitis—Citalopram—alcohol dependence	0.00101	0.00411	CcSEcCtD
Pomalidomide—Cough—Naltrexone—alcohol dependence	0.00101	0.00411	CcSEcCtD
Pomalidomide—Confusional state—Acamprosate—alcohol dependence	0.00101	0.00409	CcSEcCtD
Pomalidomide—Pancytopenia—Citalopram—alcohol dependence	0.001	0.00406	CcSEcCtD
Pomalidomide—PTGS2—adrenal cortex—alcohol dependence	0.000994	0.0155	CbGeAlD
Pomalidomide—Infection—Acamprosate—alcohol dependence	0.000992	0.00403	CcSEcCtD
Pomalidomide—Arthralgia—Naltrexone—alcohol dependence	0.000986	0.00401	CcSEcCtD
Pomalidomide—Anxiety—Naltrexone—alcohol dependence	0.000982	0.00399	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000979	0.00398	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000979	0.00398	CcSEcCtD
Pomalidomide—Thrombocytopenia—Acamprosate—alcohol dependence	0.000978	0.00397	CcSEcCtD
Pomalidomide—Skin disorder—Acamprosate—alcohol dependence	0.00097	0.00394	CcSEcCtD
Pomalidomide—Hyperhidrosis—Acamprosate—alcohol dependence	0.000965	0.00392	CcSEcCtD
Pomalidomide—Weight increased—Citalopram—alcohol dependence	0.000958	0.00389	CcSEcCtD
Pomalidomide—Confusional state—Naltrexone—alcohol dependence	0.000953	0.00387	CcSEcCtD
Pomalidomide—Weight decreased—Citalopram—alcohol dependence	0.000953	0.00387	CcSEcCtD
Pomalidomide—Hyperglycaemia—Citalopram—alcohol dependence	0.00095	0.00386	CcSEcCtD
Pomalidomide—Pneumonia—Citalopram—alcohol dependence	0.000944	0.00384	CcSEcCtD
Pomalidomide—Infection—Naltrexone—alcohol dependence	0.000939	0.00381	CcSEcCtD
Pomalidomide—Infestation—Citalopram—alcohol dependence	0.000939	0.00381	CcSEcCtD
Pomalidomide—Infestation NOS—Citalopram—alcohol dependence	0.000939	0.00381	CcSEcCtD
Pomalidomide—Nervous system disorder—Naltrexone—alcohol dependence	0.000927	0.00377	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Citalopram—alcohol dependence	0.00092	0.00374	CcSEcCtD
Pomalidomide—Skin disorder—Naltrexone—alcohol dependence	0.000918	0.00373	CcSEcCtD
Pomalidomide—Hyperhidrosis—Naltrexone—alcohol dependence	0.000913	0.00371	CcSEcCtD
Pomalidomide—Urinary tract infection—Citalopram—alcohol dependence	0.000912	0.00371	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00091	0.0037	CcSEcCtD
Pomalidomide—CYP1A2—digestive system—alcohol dependence	0.000909	0.0141	CbGeAlD
Pomalidomide—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000908	0.00998	CbGpPWpGaD
Pomalidomide—PTGS2—cardiovascular system—alcohol dependence	0.000907	0.0141	CbGeAlD
Pomalidomide—Insomnia—Acamprosate—alcohol dependence	0.000903	0.00367	CcSEcCtD
Pomalidomide—Dyspnoea—Acamprosate—alcohol dependence	0.00089	0.00362	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Citalopram—alcohol dependence	0.000888	0.00361	CcSEcCtD
Pomalidomide—Epistaxis—Citalopram—alcohol dependence	0.000885	0.0036	CcSEcCtD
Pomalidomide—PTGS2—pancreas—alcohol dependence	0.000882	0.0137	CbGeAlD
Pomalidomide—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000876	0.00964	CbGpPWpGaD
Pomalidomide—Decreased appetite—Acamprosate—alcohol dependence	0.000868	0.00353	CcSEcCtD
Pomalidomide—CYP1A2—blood—alcohol dependence	0.000866	0.0135	CbGeAlD
Pomalidomide—TNF—Spinal Cord Injury—PDYN—alcohol dependence	0.000865	0.00952	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000864	0.0095	CbGpPWpGaD
Pomalidomide—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000862	0.0035	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000861	0.0035	CcSEcCtD
Pomalidomide—Insomnia—Naltrexone—alcohol dependence	0.000855	0.00347	CcSEcCtD
Pomalidomide—Pain—Acamprosate—alcohol dependence	0.000854	0.00347	CcSEcCtD
Pomalidomide—Constipation—Acamprosate—alcohol dependence	0.000854	0.00347	CcSEcCtD
Pomalidomide—Dyspnoea—Naltrexone—alcohol dependence	0.000842	0.00342	CcSEcCtD
Pomalidomide—Urinary tract disorder—Citalopram—alcohol dependence	0.000832	0.00338	CcSEcCtD
Pomalidomide—Oedema peripheral—Citalopram—alcohol dependence	0.00083	0.00337	CcSEcCtD
Pomalidomide—Connective tissue disorder—Citalopram—alcohol dependence	0.000828	0.00336	CcSEcCtD
Pomalidomide—Urethral disorder—Citalopram—alcohol dependence	0.000826	0.00336	CcSEcCtD
Pomalidomide—Feeling abnormal—Acamprosate—alcohol dependence	0.000823	0.00334	CcSEcCtD
Pomalidomide—Decreased appetite—Naltrexone—alcohol dependence	0.000821	0.00334	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000816	0.00331	CcSEcCtD
Pomalidomide—Fatigue—Naltrexone—alcohol dependence	0.000815	0.00331	CcSEcCtD
Pomalidomide—Constipation—Naltrexone—alcohol dependence	0.000808	0.00328	CcSEcCtD
Pomalidomide—Pain—Naltrexone—alcohol dependence	0.000808	0.00328	CcSEcCtD
Pomalidomide—PTGS2—Selenium Micronutrient Network—GGT2—alcohol dependence	0.000796	0.00876	CbGpPWpGaD
Pomalidomide—Body temperature increased—Acamprosate—alcohol dependence	0.00079	0.00321	CcSEcCtD
Pomalidomide—Cardiac disorder—Citalopram—alcohol dependence	0.000782	0.00318	CcSEcCtD
Pomalidomide—Feeling abnormal—Naltrexone—alcohol dependence	0.000779	0.00316	CcSEcCtD
Pomalidomide—Angiopathy—Citalopram—alcohol dependence	0.000765	0.00311	CcSEcCtD
Pomalidomide—Mediastinal disorder—Citalopram—alcohol dependence	0.000759	0.00309	CcSEcCtD
Pomalidomide—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.000759	0.00835	CbGpPWpGaD
Pomalidomide—Chills—Citalopram—alcohol dependence	0.000756	0.00307	CcSEcCtD
Pomalidomide—PTGS2—digestive system—alcohol dependence	0.000753	0.0117	CbGeAlD
Pomalidomide—CYP1A2—endocrine gland—alcohol dependence	0.000751	0.0117	CbGeAlD
Pomalidomide—Body temperature increased—Naltrexone—alcohol dependence	0.000747	0.00304	CcSEcCtD
Pomalidomide—Mental disorder—Citalopram—alcohol dependence	0.000738	0.003	CcSEcCtD
Pomalidomide—Hypersensitivity—Acamprosate—alcohol dependence	0.000736	0.00299	CcSEcCtD
Pomalidomide—Malnutrition—Citalopram—alcohol dependence	0.000734	0.00298	CcSEcCtD
Pomalidomide—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00073	0.00803	CbGpPWpGaD
Pomalidomide—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000726	0.00799	CbGpPWpGaD
Pomalidomide—PTGS2—blood—alcohol dependence	0.000717	0.0112	CbGeAlD
Pomalidomide—Asthenia—Acamprosate—alcohol dependence	0.000717	0.00291	CcSEcCtD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000716	0.00787	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—GRIN2B—alcohol dependence	0.000715	0.00786	CbGpPWpGaD
Pomalidomide—Back pain—Citalopram—alcohol dependence	0.00071	0.00288	CcSEcCtD
Pomalidomide—PTGS2—midbrain—alcohol dependence	0.000709	0.011	CbGeAlD
Pomalidomide—Pruritus—Acamprosate—alcohol dependence	0.000707	0.00287	CcSEcCtD
Pomalidomide—Muscle spasms—Citalopram—alcohol dependence	0.000705	0.00287	CcSEcCtD
Pomalidomide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.0007	0.00771	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Naltrexone—alcohol dependence	0.000696	0.00283	CcSEcCtD
Pomalidomide—Tremor—Citalopram—alcohol dependence	0.000687	0.00279	CcSEcCtD
Pomalidomide—Diarrhoea—Acamprosate—alcohol dependence	0.000683	0.00278	CcSEcCtD
Pomalidomide—Anaemia—Citalopram—alcohol dependence	0.000678	0.00276	CcSEcCtD
Pomalidomide—Asthenia—Naltrexone—alcohol dependence	0.000678	0.00275	CcSEcCtD
Pomalidomide—CYP1A2—liver—alcohol dependence	0.000677	0.0105	CbGeAlD
Pomalidomide—Pruritus—Naltrexone—alcohol dependence	0.000669	0.00272	CcSEcCtD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000667	0.00733	CbGpPWpGaD
Pomalidomide—ABCB1—forebrain—alcohol dependence	0.000664	0.0103	CbGeAlD
Pomalidomide—Dizziness—Acamprosate—alcohol dependence	0.00066	0.00268	CcSEcCtD
Pomalidomide—Vertigo—Citalopram—alcohol dependence	0.000659	0.00268	CcSEcCtD
Pomalidomide—CYP3A4—digestive system—alcohol dependence	0.000658	0.0102	CbGeAlD
Pomalidomide—Leukopenia—Citalopram—alcohol dependence	0.000657	0.00267	CcSEcCtD
Pomalidomide—Diarrhoea—Naltrexone—alcohol dependence	0.000647	0.00263	CcSEcCtD
Pomalidomide—Cough—Citalopram—alcohol dependence	0.00064	0.0026	CcSEcCtD
Pomalidomide—Vomiting—Acamprosate—alcohol dependence	0.000635	0.00258	CcSEcCtD
Pomalidomide—Rash—Acamprosate—alcohol dependence	0.00063	0.00256	CcSEcCtD
Pomalidomide—Dermatitis—Acamprosate—alcohol dependence	0.000629	0.00256	CcSEcCtD
Pomalidomide—CYP3A4—blood—alcohol dependence	0.000627	0.00975	CbGeAlD
Pomalidomide—Headache—Acamprosate—alcohol dependence	0.000626	0.00254	CcSEcCtD
Pomalidomide—Dizziness—Naltrexone—alcohol dependence	0.000625	0.00254	CcSEcCtD
Pomalidomide—Arthralgia—Citalopram—alcohol dependence	0.000625	0.00254	CcSEcCtD
Pomalidomide—Anxiety—Citalopram—alcohol dependence	0.000622	0.00253	CcSEcCtD
Pomalidomide—PTGS2—endocrine gland—alcohol dependence	0.000622	0.00968	CbGeAlD
Pomalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000622	0.00684	CbGpPWpGaD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00062	0.00252	CcSEcCtD
Pomalidomide—ABCB1—adrenal cortex—alcohol dependence	0.000615	0.00957	CbGeAlD
Pomalidomide—TNF—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000609	0.0067	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000609	0.00669	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000605	0.00666	CbGpPWpGaD
Pomalidomide—Confusional state—Citalopram—alcohol dependence	0.000604	0.00245	CcSEcCtD
Pomalidomide—Vomiting—Naltrexone—alcohol dependence	0.000601	0.00244	CcSEcCtD
Pomalidomide—Rash—Naltrexone—alcohol dependence	0.000596	0.00242	CcSEcCtD
Pomalidomide—Dermatitis—Naltrexone—alcohol dependence	0.000595	0.00242	CcSEcCtD
Pomalidomide—Infection—Citalopram—alcohol dependence	0.000595	0.00242	CcSEcCtD
Pomalidomide—Nausea—Acamprosate—alcohol dependence	0.000593	0.00241	CcSEcCtD
Pomalidomide—Headache—Naltrexone—alcohol dependence	0.000592	0.00241	CcSEcCtD
Pomalidomide—PTGS2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000592	0.00651	CbGpPWpGaD
Pomalidomide—Nervous system disorder—Citalopram—alcohol dependence	0.000587	0.00239	CcSEcCtD
Pomalidomide—Thrombocytopenia—Citalopram—alcohol dependence	0.000586	0.00238	CcSEcCtD
Pomalidomide—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000586	0.00645	CbGpPWpGaD
Pomalidomide—PTGS2—nervous system—alcohol dependence	0.000582	0.00906	CbGeAlD
Pomalidomide—Skin disorder—Citalopram—alcohol dependence	0.000582	0.00236	CcSEcCtD
Pomalidomide—Hyperhidrosis—Citalopram—alcohol dependence	0.000579	0.00235	CcSEcCtD
Pomalidomide—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.000574	0.00631	CbGpPWpGaD
Pomalidomide—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000564	0.0062	CbGpPWpGaD
Pomalidomide—Nausea—Naltrexone—alcohol dependence	0.000561	0.00228	CcSEcCtD
Pomalidomide—ABCB1—cardiovascular system—alcohol dependence	0.000561	0.00873	CbGeAlD
Pomalidomide—PTGS2—liver—alcohol dependence	0.000561	0.00873	CbGeAlD
Pomalidomide—PTGS2—central nervous system—alcohol dependence	0.000561	0.00872	CbGeAlD
Pomalidomide—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00056	0.00617	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000552	0.00608	CbGpPWpGaD
Pomalidomide—PTGS2—cerebellum—alcohol dependence	0.000548	0.00853	CbGeAlD
Pomalidomide—ABCB1—pancreas—alcohol dependence	0.000545	0.00849	CbGeAlD
Pomalidomide—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000545	0.00222	CcSEcCtD
Pomalidomide—CYP3A4—endocrine gland—alcohol dependence	0.000544	0.00846	CbGeAlD
Pomalidomide—Insomnia—Citalopram—alcohol dependence	0.000542	0.0022	CcSEcCtD
Pomalidomide—PTGS2—Spinal Cord Injury—PDYN—alcohol dependence	0.000535	0.00589	CbGpPWpGaD
Pomalidomide—Dyspnoea—Citalopram—alcohol dependence	0.000534	0.00217	CcSEcCtD
Pomalidomide—Decreased appetite—Citalopram—alcohol dependence	0.00052	0.00211	CcSEcCtD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000517	0.00569	CbGpPWpGaD
Pomalidomide—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000517	0.0021	CcSEcCtD
Pomalidomide—Fatigue—Citalopram—alcohol dependence	0.000516	0.0021	CcSEcCtD
Pomalidomide—Constipation—Citalopram—alcohol dependence	0.000512	0.00208	CcSEcCtD
Pomalidomide—Pain—Citalopram—alcohol dependence	0.000512	0.00208	CcSEcCtD
Pomalidomide—ABCB1—gonad—alcohol dependence	0.000509	0.00792	CbGeAlD
Pomalidomide—CYP3A4—nervous system—alcohol dependence	0.000509	0.00792	CbGeAlD
Pomalidomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000497	0.00546	CbGpPWpGaD
Pomalidomide—Feeling abnormal—Citalopram—alcohol dependence	0.000493	0.002	CcSEcCtD
Pomalidomide—CYP3A4—liver—alcohol dependence	0.00049	0.00763	CbGeAlD
Pomalidomide—CYP3A4—central nervous system—alcohol dependence	0.00049	0.00762	CbGeAlD
Pomalidomide—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000488	0.00537	CbGpPWpGaD
Pomalidomide—Body temperature increased—Citalopram—alcohol dependence	0.000473	0.00192	CcSEcCtD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00047	0.00517	CbGpPWpGaD
Pomalidomide—ABCB1—digestive system—alcohol dependence	0.000466	0.00725	CbGeAlD
Pomalidomide—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000464	0.0051	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.000459	0.00505	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000459	0.00504	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000454	0.00499	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.00045	0.00496	CbGpPWpGaD
Pomalidomide—PTGS2—brain—alcohol dependence	0.000445	0.00693	CbGeAlD
Pomalidomide—ABCB1—blood—alcohol dependence	0.000444	0.0069	CbGeAlD
Pomalidomide—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000443	0.00487	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Citalopram—alcohol dependence	0.000441	0.00179	CcSEcCtD
Pomalidomide—ABCB1—midbrain—alcohol dependence	0.000438	0.00682	CbGeAlD
Pomalidomide—Asthenia—Citalopram—alcohol dependence	0.00043	0.00175	CcSEcCtD
Pomalidomide—Pruritus—Citalopram—alcohol dependence	0.000424	0.00172	CcSEcCtD
Pomalidomide—Diarrhoea—Citalopram—alcohol dependence	0.00041	0.00166	CcSEcCtD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000399	0.00439	CbGpPWpGaD
Pomalidomide—Dizziness—Citalopram—alcohol dependence	0.000396	0.00161	CcSEcCtD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000396	0.00435	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000396	0.00435	CbGpPWpGaD
Pomalidomide—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.00039	0.00429	CbGpPWpGaD
Pomalidomide—ABCB1—endocrine gland—alcohol dependence	0.000385	0.00599	CbGeAlD
Pomalidomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000383	0.00422	CbGpPWpGaD
Pomalidomide—Vomiting—Citalopram—alcohol dependence	0.000381	0.00155	CcSEcCtD
Pomalidomide—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.00038	0.00418	CbGpPWpGaD
Pomalidomide—Rash—Citalopram—alcohol dependence	0.000377	0.00153	CcSEcCtD
Pomalidomide—Dermatitis—Citalopram—alcohol dependence	0.000377	0.00153	CcSEcCtD
Pomalidomide—PTGS2—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000377	0.00414	CbGpPWpGaD
Pomalidomide—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000376	0.00414	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000376	0.00414	CbGpPWpGaD
Pomalidomide—Headache—Citalopram—alcohol dependence	0.000375	0.00152	CcSEcCtD
Pomalidomide—ABCB1—testis—alcohol dependence	0.000367	0.00571	CbGeAlD
Pomalidomide—ABCB1—nervous system—alcohol dependence	0.00036	0.00561	CbGeAlD
Pomalidomide—Nausea—Citalopram—alcohol dependence	0.000356	0.00145	CcSEcCtD
Pomalidomide—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000354	0.0039	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00035	0.00385	CbGpPWpGaD
Pomalidomide—TNF—TGF-beta Receptor Signaling—EP300—alcohol dependence	0.000348	0.00383	CbGpPWpGaD
Pomalidomide—ABCB1—liver—alcohol dependence	0.000347	0.0054	CbGeAlD
Pomalidomide—ABCB1—central nervous system—alcohol dependence	0.000347	0.0054	CbGeAlD
Pomalidomide—TNF—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000345	0.0038	CbGpPWpGaD
Pomalidomide—ABCB1—cerebellum—alcohol dependence	0.000339	0.00527	CbGeAlD
Pomalidomide—TNF—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000338	0.00372	CbGpPWpGaD
Pomalidomide—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000335	0.00368	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.000323	0.00356	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00032	0.00352	CbGpPWpGaD
Pomalidomide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000315	0.00347	CbGpPWpGaD
Pomalidomide—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000311	0.00342	CbGpPWpGaD
Pomalidomide—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000301	0.00331	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000293	0.00323	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00029	0.00319	CbGpPWpGaD
Pomalidomide—TNF—Signaling events mediated by HDAC Class I—EP300—alcohol dependence	0.000283	0.00311	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000281	0.00309	CbGpPWpGaD
Pomalidomide—ABCB1—brain—alcohol dependence	0.000275	0.00428	CbGeAlD
Pomalidomide—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000275	0.00302	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.000264	0.0029	CbGpPWpGaD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—alcohol dependence	0.000262	0.00288	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000256	0.00281	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000249	0.00274	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000247	0.00271	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000245	0.00269	CbGpPWpGaD
Pomalidomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000243	0.00268	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000241	0.00265	CbGpPWpGaD
Pomalidomide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00024	0.00264	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000213	0.00234	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000212	0.00233	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00021	0.00231	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000203	0.00224	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.0002	0.0022	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000197	0.00217	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000186	0.00205	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.00017	0.00187	CbGpPWpGaD
Pomalidomide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000169	0.00186	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—GRIN2B—alcohol dependence	0.000165	0.00181	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000162	0.00179	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000154	0.0017	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—EP300—alcohol dependence	0.000151	0.00166	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000149	0.00164	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADH6—alcohol dependence	0.000139	0.00153	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000139	0.00152	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000139	0.00152	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000137	0.00151	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.000136	0.00149	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000134	0.00147	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000131	0.00144	CbGpPWpGaD
Pomalidomide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00013	0.00143	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.00013	0.00143	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000127	0.00139	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000126	0.00138	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GGT1—alcohol dependence	0.000125	0.00137	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADH1A—alcohol dependence	0.000115	0.00126	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—MAOA—alcohol dependence	0.000112	0.00123	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000107	0.00118	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000106	0.00116	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000105	0.00115	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000103	0.00114	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADH6—alcohol dependence	9.83e-05	0.00108	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADH4—alcohol dependence	9.77e-05	0.00107	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GGT1—alcohol dependence	9.62e-05	0.00106	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—MAOA—alcohol dependence	8.62e-05	0.000948	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	8.46e-05	0.00093	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADH7—alcohol dependence	8.31e-05	0.000914	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADH1A—alcohol dependence	8.14e-05	0.000896	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GGT2—alcohol dependence	7.96e-05	0.000876	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADH6—alcohol dependence	7.85e-05	0.000863	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	7.84e-05	0.000862	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADH1B—alcohol dependence	7.28e-05	0.000801	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—POMC—alcohol dependence	7.27e-05	0.0008	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADH4—alcohol dependence	6.93e-05	0.000762	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADH1A—alcohol dependence	6.5e-05	0.000715	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADH6—alcohol dependence	6.06e-05	0.000666	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	6.05e-05	0.000666	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MAOB—alcohol dependence	6.04e-05	0.000664	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—EP300—alcohol dependence	5.93e-05	0.000652	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADH7—alcohol dependence	5.89e-05	0.000648	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GGT2—alcohol dependence	5.65e-05	0.000621	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—POMC—alcohol dependence	5.61e-05	0.000617	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	5.56e-05	0.000611	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADH4—alcohol dependence	5.53e-05	0.000608	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GOT2—alcohol dependence	5.21e-05	0.000573	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADH1B—alcohol dependence	5.16e-05	0.000568	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALDH2—alcohol dependence	5.13e-05	0.000565	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADH1A—alcohol dependence	5.02e-05	0.000552	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	5.01e-05	0.000551	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.93e-05	0.000543	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	4.79e-05	0.000527	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADH7—alcohol dependence	4.7e-05	0.000517	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GGT2—alcohol dependence	4.51e-05	0.000496	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GOT1—alcohol dependence	4.5e-05	0.000495	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GOT2—alcohol dependence	4.36e-05	0.00048	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MAOB—alcohol dependence	4.28e-05	0.000471	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADH4—alcohol dependence	4.27e-05	0.000469	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADH1B—alcohol dependence	4.12e-05	0.000453	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2E1—alcohol dependence	4.1e-05	0.000451	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GGT1—alcohol dependence	3.77e-05	0.000414	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GOT1—alcohol dependence	3.77e-05	0.000414	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALDH2—alcohol dependence	3.64e-05	0.0004	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADH7—alcohol dependence	3.63e-05	0.000399	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GGT2—alcohol dependence	3.48e-05	0.000383	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MAOB—alcohol dependence	3.42e-05	0.000376	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MAOA—alcohol dependence	3.38e-05	0.000371	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.27e-05	0.00036	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.18e-05	0.00035	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GOT2—alcohol dependence	3.09e-05	0.00034	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2E1—alcohol dependence	2.91e-05	0.00032	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALDH2—alcohol dependence	2.9e-05	0.000319	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.79e-05	0.000307	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GOT1—alcohol dependence	2.67e-05	0.000294	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GGT1—alcohol dependence	2.67e-05	0.000294	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MAOB—alcohol dependence	2.64e-05	0.00029	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GOT2—alcohol dependence	2.47e-05	0.000272	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MAOA—alcohol dependence	2.39e-05	0.000263	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2E1—alcohol dependence	2.32e-05	0.000255	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.24e-05	0.000247	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—alcohol dependence	2.2e-05	0.000242	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GOT1—alcohol dependence	2.13e-05	0.000234	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GGT1—alcohol dependence	2.13e-05	0.000234	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MAOA—alcohol dependence	1.91e-05	0.00021	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GOT2—alcohol dependence	1.91e-05	0.00021	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.85e-05	0.000204	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.79e-05	0.000197	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EP300—alcohol dependence	1.74e-05	0.000191	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GOT1—alcohol dependence	1.65e-05	0.000181	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GGT1—alcohol dependence	1.65e-05	0.000181	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—alcohol dependence	1.56e-05	0.000171	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MAOA—alcohol dependence	1.47e-05	0.000162	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—EP300—alcohol dependence	1.46e-05	0.00016	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—alcohol dependence	1.24e-05	0.000137	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—EP300—alcohol dependence	1.03e-05	0.000114	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—alcohol dependence	9.6e-06	0.000106	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—EP300—alcohol dependence	8.25e-06	9.08e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—EP300—alcohol dependence	6.37e-06	7e-05	CbGpPWpGaD
